Close Menu

NEW YORK — Zymo Research said on Tuesday that it has received CE-IVD marking for its Quick SARS-CoV-2 Multiplex Kit.

The real-time reverse transcription PCR test is designed for the qualitative detection of SARS-CoV-2 nucleic acid in upper and lower respiratory specimens. According to the Irvine, California-based company, the kit has a limit of detection of 10-virus copies per reaction and up to 382 samples can be analyzed for each RT-PCR run.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.